发明名称 |
CRYSTALLINE R-(R*,R*))-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL)-1H-PYRROLE-1-HEPTANOIC ACID HEMI CALCIUM SALT (ATORVASTATIN) |
摘要 |
<p>There are described novel crystalline forms of ÄR-(R*,R*)Ü-2-(4-fluorophenyl)- beta , delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-Ä(phenylamino)carbonylÜ-1H-pyr role-l-heptanoic acid hemi calcium salt designated Form II and Form IV which are characterized by their X-ray powder diffraction and/or solid state NMR, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia and hypercholesterolemia.</p> |
申请公布号 |
SI848705(T1) |
申请公布日期 |
2002.04.30 |
申请号 |
SI19960030355T |
申请日期 |
1996.07.08 |
申请人 |
WARNER-LAMBERT COMPANY |
发明人 |
BRIGGS CHRISTOPHER A.;JENNINGS REX ALLEN;WADE ROBERT A.;HARASAWA KIKUKO;ICHIKAWA SHIGERU;MINOHARA KAZUO;NAKAGAWA SHINSUKE |
分类号 |
C07D207/34;A61K31/40;A61P3/06;A61P3/14;A61P43/00;C07D;(IPC1-7):C07D207/34 |
主分类号 |
C07D207/34 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|